EFFECTOR THERAPEUTICS INC - COM (EFTR)

CUSIP: 28202V108

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
13,427,760
Share change
+9,118,431
Total reported value
$127,452,546
Price per share
$14.04
Number of holders
11
Value change
+$127,392,000
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 28202V108?
CUSIP 28202V108 identifies EFTR - EFFECTOR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EFFECTOR THERAPEUTICS INC - COM (EFTR) as of Q3 2021

As of 30 Sep 2021, EFFECTOR THERAPEUTICS INC - COM (EFTR) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,427,760 shares. The largest 10 holders included Abingworth LLP, Column Group LLC, Sectoral Asset Management Inc, Blackstone Inc, Verition Fund Management LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, Virtu Financial LLC, CITADEL ADVISORS LLC, and Tower Research Capital LLC (TRC). This page lists 11 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.